Brensocatib Impurity 37 | CAS 62129-44-6 - Request Quote
Brensocatib Impurity 37
| SZ CAT No: | SZ-B145044 |
| CAS No | 62129-44-6 |
| Mol.F. | C14H18INO4 |
| Mol.Wt. |
391.2 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Brensocatib Impurity 37 is chemically (S)-2-((tert-butoxycarbonyl)amino)-3-(4-iodophenyl)propanoic acid. Brensocatib Impurity 37 is supplied with detailed characterization data compliant with regulatory guideline. Brensocatib Impurity 37 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Brensocatib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 62129-44-6
Purchase 62129-44-6
Order 62129-44-6
Enquire 62129-44-6
price of 62129-44-6
62129-44-6 Supplier
62129-44-6 Manufacturer
62129-44-6 Exporter
buy high quality Brensocatib Impurity 37
Purchase Brensocatib Impurity 37
Brensocatib Impurity 37 suppliers
Brensocatib Impurity 37 manufacturers
Brensocatib Impurity 37 price
Order Brensocatib Impurity 37
Enquire Brensocatib Impurity 37
Brensocatib Impurity 37 cost
Brensocatib Impurity 37 Supplier
Brensocatib Impurity 37 Distributor
Brensocatib Impurity 37 for Method Validation
Brensocatib Reference Standard
Brensocatib Impurity 37 for ANDA Filing
Brensocatib Impurity 37 for Forced Degradation Studies
Brensocatib Impurity 37 Identification Standards
Brensocatib Impurity 37 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.